Drug Pipeline

SKB571 for injection Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
1
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-03 NCT07622186 A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer… Phase 2 Not Yet Recruiting
Active Studies by Phase
Phase 2
4
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07308106 A Phase II Clinical Study of SKB571 as Monotherapy in Patients With Locally Advanced or… Non-small Lung Cancer Recruiting
NCT07230405 A Phase II Study of SKB571 in Patients With Lung Cancer Lung Cancer (Non-Small Cell) Recruiting
NCT07564466 A Study of SKB571 in Participants With Gastrointestinal Tumors Gastrointestinal Tumors Not Yet Recruiting
NCT07622186 A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer… Non-Small Cell Lung Cancer Not Yet Recruiting
Sponsors Running SKB571 for injection Trials
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (4)
Disease Areas
Lung Cancer (3) Non-Small Cell Lung Cancer (NSCLC) (1)
Get alerts when SKB571 for injection trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free